Movatterモバイル変換


[0]ホーム

URL:


GB1508977A - Beta-lactam antibiotic from streptomyces clavuligerus - Google Patents

Beta-lactam antibiotic from streptomyces clavuligerus

Info

Publication number
GB1508977A
GB1508977AGB17410/74AGB1741074AGB1508977AGB 1508977 AGB1508977 AGB 1508977AGB 17410/74 AGB17410/74 AGB 17410/74AGB 1741074 AGB1741074 AGB 1741074AGB 1508977 AGB1508977 AGB 1508977A
Authority
GB
United Kingdom
Prior art keywords
acid
cephaloglycine
benzylpenicillin
ticarcillin
carbenicillin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB17410/74A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLCfiledCriticalBeecham Group PLC
Priority to GB17410/74ApriorityCriticalpatent/GB1508977A/en
Priority to IE792/75Aprioritypatent/IE41109B1/en
Priority to IE1987/78Aprioritypatent/IE41110B1/en
Priority to NZ177159Aprioritypatent/NZ177159A/en
Priority to YU908/75Aprioritypatent/YU39941B/en
Priority to FR7511344Aprioritypatent/FR2267778B1/fr
Priority to CY1078Aprioritypatent/CY1078A/en
Priority to BE155402Aprioritypatent/BE827926A/en
Priority to IN743/CAL/75Aprioritypatent/IN140042B/en
Priority to IL47087Aprioritypatent/IL47087A/en
Priority to AU80177/75Aprioritypatent/AU499171B2/en
Priority to FI751133Aprioritypatent/FI54144C/en
Priority to SU752129801Aprioritypatent/SU648117A3/en
Priority to DD7500193531Aprioritypatent/DD132297A5/en
Priority to DE2559411Aprioritypatent/DE2559411C2/en
Priority to LU72322Aprioritypatent/LU72322A1/xx
Priority to MX513175Uprioritypatent/MX3973E/en
Priority to DE2560074Aprioritypatent/DE2560074C2/en
Priority to CS752721Aprioritypatent/CS231157B2/en
Priority to MX513075Uprioritypatent/MX4009E/en
Priority to DK167275AAprioritypatent/DK141254B/en
Priority to ES436766Aprioritypatent/ES436766A1/en
Priority to ZA00752492Aprioritypatent/ZA752492B/en
Priority to NL7504621.Aprioritypatent/NL163824C/en
Priority to AR258435Aprioritypatent/AR206627A1/en
Priority to HU75BE1267Aprioritypatent/HU173700B/en
Priority to NO751407Aprioritypatent/NO145247C/en
Priority to AT298575Aprioritypatent/AT352270B/en
Priority to DD185542Aprioritypatent/DD121799A5/xx
Priority to DE2517316Aprioritypatent/DE2517316C2/en
Priority to DE19752559410prioritypatent/DE2559410A1/en
Priority to CA224,970Aprioritypatent/CA1059050A/en
Priority to SE7504541Aprioritypatent/SE422063B/en
Priority to JP50048087Aprioritypatent/JPS5246957B2/ja
Priority to JP50048086Aprioritypatent/JPS521996B2/ja
Priority to OA55480Aprioritypatent/OA05203A/en
Priority to EG33575Aprioritypatent/EG12445A/en
Priority to RO7582037Aprioritypatent/RO69984A/en
Priority to RO7595311Aprioritypatent/RO77320A/en
Priority to CH506075Aprioritypatent/CH629252A5/en
Priority to PH17082Aprioritypatent/PH16474A/en
Priority to AR261404Aprioritypatent/AR219050A1/en
Priority to AR261403Aprioritypatent/AR216430A1/en
Priority to US05/726,061prioritypatent/US4110165A/en
Priority to US06/726,224prioritypatent/US4427690A/en
Priority to JP16090276Aprioritypatent/JPS5285189A/en
Priority to AT205377Aprioritypatent/AT353407B/en
Priority to AT205277Aprioritypatent/AT350718B/en
Priority to AT205477Aprioritypatent/AT350719B/en
Priority to AT205577Aprioritypatent/AT348124B/en
Priority to JP4026177Aprioritypatent/JPS533590A/en
Priority to JP4026077Aprioritypatent/JPS533589A/en
Priority to JP4025977Aprioritypatent/JPS533588A/en
Priority to JP4025877Aprioritypatent/JPS532495A/en
Priority to JP4025777Aprioritypatent/JPS532494A/en
Priority to FI780201Aprioritypatent/FI58332C/en
Priority to FI780202Aprioritypatent/FI780202A/en
Publication of GB1508977ApublicationCriticalpatent/GB1508977A/en
Priority to DK287378Aprioritypatent/DK150489C/en
Priority to DK287078Aprioritypatent/DK145543C/en
Priority to DK287278Aprioritypatent/DK150488C/en
Priority to DK287178Aprioritypatent/DK287178A/en
Priority to US05/924,174prioritypatent/US4556559A/en
Priority to SE7811200Aprioritypatent/SE435286B/en
Priority to SE7811201Aprioritypatent/SE446687B/en
Priority to SE7811203Aprioritypatent/SE443562B/en
Priority to SE7811202Aprioritypatent/SE435287B/en
Priority to CA314,882Aprioritypatent/CA1076120A/en
Priority to CA314,881Aprioritypatent/CA1074325A/en
Priority to CA314,880Aprioritypatent/CA1055395A/en
Priority to NO791956Aprioritypatent/NO150838C/en
Priority to NO801852Aprioritypatent/NO801852L/en
Priority to DK286980Aprioritypatent/DK157302C/en
Priority to KE3076Aprioritypatent/KE3076A/en
Priority to HK547/80Aprioritypatent/HK54780A/en
Priority to CH947280Aprioritypatent/CH630631A5/en
Priority to US06/272,030prioritypatent/US4526783A/en
Priority to US06/305,337prioritypatent/US4529720A/en
Priority to SE8105829Aprioritypatent/SE453600B/en
Priority to YU2743/81Aprioritypatent/YU42744B/en
Priority to YU2744/81Aprioritypatent/YU42745B/en
Priority to US06/327,253prioritypatent/US4525352A/en
Priority to US06330456prioritypatent/US4560552C1/en
Priority to MY195/81Aprioritypatent/MY8100195A/en
Priority to US06/352,951prioritypatent/US4525353A/en
Priority to SE8306328Aprioritypatent/SE8306328D0/en
Priority to SE8605405Aprioritypatent/SE8605405D0/en
Expiredlegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

1508977 Antibiotic compositions containing clavulanic add BEECHAM GROUP Ltd 11 April 1975 17410/74 27715/74 43651/74 and 53525/74 Heading A5B [Also in Division C2] Pharmaceutical compositions having antibacterial activity comprise, as active ingredient clavulanic acid of the formula or a pharceutically acceptable salt thereof, together with a pharmaceutically acceptable carrier and optionally other therapeutically active agents such as #-lactam antibiotics, e.g. benzylpenicillin, phenoxymethylpenicillin, carbenicillin, methicillin, propioillin, ampicillin, amoxycillin, epicillin, ticarcillin, cyclacillin, 6- aminopenicillanic acid, 7 - aminocephalosporanic acid, 7 - aminodesacetoxycephalosporanic acid, cephaloridine, cephalothin, cephazolin, cephalexin, cefoxitin, cephacetrile, cephamandole, cephapirin, cephradine, cephaloglycine, hetaoillin, metampicillin, the acetoxymethyl, pivaloyloxymethyl or phthalidyl esters of benzylpenicillin, ampicillin, amoxyoillin or cephaloglycine or the phenyl, tolyl or indanyl α-esters of carbenicillin or ticarcillin. They may be administered orally, topically or parenterally e.g. as tablets, capsules, creams, syrups, suspensions, solutions, reconstitutable powders and sterile forms suitable for injection or infusion.
GB17410/74A1973-05-041974-04-20Beta-lactam antibiotic from streptomyces clavuligerusExpiredGB1508977A (en)

Priority Applications (86)

Application NumberPriority DateFiling DateTitle
GB17410/74AGB1508977A (en)1974-04-201974-04-20Beta-lactam antibiotic from streptomyces clavuligerus
IE792/75AIE41109B1 (en)1974-04-201975-04-08Novel -lactam antibiotic from streptomyces clavuligerus
IE1987/78AIE41110B1 (en)1974-04-201975-04-08Esters of clavulanic acid
NZ177159ANZ177159A (en)1974-04-201975-04-08Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions
YU908/75AYU39941B (en)1974-04-201975-04-09Process for obtaining clavulanic acid
FR7511344AFR2267778B1 (en)1974-04-201975-04-11
CY1078ACY1078A (en)1974-04-201975-04-11Beta-lactam antibiotic from strepomyces clavuligerus
BE155402ABE827926A (en)1974-04-201975-04-14 ANTIBIOTIC
IN743/CAL/75AIN140042B (en)1974-04-201975-04-14
IL47087AIL47087A (en)1974-04-201975-04-14Antibiotic compounds obtained from streptomyces clavuligerus their preparation and pharmaceutical compositions containig them
AU80177/75AAU499171B2 (en)1973-05-041975-04-15Clavulanic acid derivatives
FI751133AFI54144C (en)1974-04-201975-04-16 FOERFARANDE FOER FRAMSTAELLNING AV KLAVULANSYRA ELLER ETT SALT DAERAV
SU752129801ASU648117A3 (en)1974-04-201975-04-18Method of obtaining antibacterial substance
DD7500193531ADD132297A5 (en)1974-04-201975-04-18 METHOD FOR PRODUCING A SYNERGISTIC PHARMACEUTICAL AGENT
DE2559411ADE2559411C2 (en)1974-04-201975-04-18 Use of clavulanic acid
LU72322ALU72322A1 (en)1974-04-201975-04-18
MX513175UMX3973E (en)1974-04-201975-04-18 PROCEDURE FOR THE PREPARATION OF CLAVULANIC ACID ESTERS
DE2560074ADE2560074C2 (en)1974-04-201975-04-18 Process for the production of clavulanic acid and its salts
CS752721ACS231157B2 (en)1974-04-201975-04-18Processing method of klavulan acid and corresponding salts and esters
MX513075UMX4009E (en)1974-04-201975-04-18 PROCEDURE FOR THE PREPARATION OF CLAVANIC ACID ESTERS
DK167275AADK141254B (en)1974-04-201975-04-18 Process for preparing clavulanic acid or a salt or ester thereof.
ES436766AES436766A1 (en)1974-04-201975-04-18A procedure for the preparation of a clavulan acid salt. (Machine-translation by Google Translate, not legally binding)
ZA00752492AZA752492B (en)1974-04-201975-04-18Antibiotics
NL7504621.ANL163824C (en)1974-04-201975-04-18 PROCESS FOR THE RECOVERY OF AN ANTIBIOTIC WITH AN EFFICIENCY AGAINST BACTERIA CALLED CLAVULANIC ACID, PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS CONTAINING THIS ANTIBIOTIC PRODUCT OR A SALT OR ESTER PREPARED THEREFORE, INCLUDING PREPARATIONS
AR258435AAR206627A1 (en)1974-04-201975-04-18 PROCEDURE FOR THE PREPARATION OF CALVULANIC ACID
HU75BE1267AHU173700B (en)1974-04-201975-04-18Process for producing esters of clavulanic acid
NO751407ANO145247C (en)1974-04-201975-04-18 PROCEDURE FOR THE PREPARATION OF CLAVULANIC ACID
AT298575AAT352270B (en)1974-04-201975-04-18 METHOD FOR PRODUCING THE NEW CLAVULANIC ACIDS
DD185542ADD121799A5 (en)1974-04-201975-04-18
DE2517316ADE2517316C2 (en)1974-04-201975-04-18 Clavulanic acid and its salts and medicinal products containing these compounds
DE19752559410DE2559410A1 (en)1974-04-201975-04-18 ESTERS OF CLAVULANIC ACIDS, THE PROCESS FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
CA224,970ACA1059050A (en)1974-04-201975-04-18Clavulanic acid from streptomyces clavuligerus
SE7504541ASE422063B (en)1974-04-201975-04-18 PROCEDURE FOR PREPARING ANIBIOTICS FROM S.CLOVULIGERUS
JP50048087AJPS5246957B2 (en)1974-04-201975-04-19
JP50048086AJPS521996B2 (en)1974-04-201975-04-19
OA55480AOA05203A (en)1974-04-201975-04-19 New Antibiotics.
EG33575AEG12445A (en)1974-04-201975-04-19Process for preparing of antibiotics
RO7582037ARO69984A (en)1974-04-201975-04-19 CLAVULIAN ACID PROCESSING PROCEDURE
RO7595311ARO77320A (en)1974-04-201975-04-19 PROCEDURE FOR THE PURIFICATION OF CLAVULANIC ACID SALTS
CH506075ACH629252A5 (en)1974-04-201975-04-21 METHOD FOR THE PRODUCTION OF CLAVULANIC ACID AND ITS SALTS.
PH17082APH16474A (en)1974-04-201975-04-21Clavulcanic acid,salts and esters thereof and pharmaceutical compositions containing same
AR261404AAR219050A1 (en)1974-04-201975-11-28 PROCEDURE FOR THE PREPARATION OF ESTERS OF THE CLAVULANIC ACID
AR261403AAR216430A1 (en)1974-04-201975-11-28 A PROCEDURE FOR THE PREPARATION OF CLAVULANIC ACID ESTERS
US05/726,061US4110165A (en)1974-04-201976-09-24Process for the production of clavulanic acid
US06/726,224US4427690A (en)1974-04-201976-09-24Esters of clavulanic acid
JP16090276AJPS5285189A (en)1974-04-201976-12-28Process for preparing antibiotics
AT205377AAT353407B (en)1974-04-201977-03-24 METHOD FOR PREPARING SYNERGISTIC ANTIBACTERIAL COMPOSITIONS
AT205277AAT350718B (en)1974-04-201977-03-24 PROCESS FOR THE PRODUCTION OF NEW CLAVULAN ACID ESTERS
AT205477AAT350719B (en)1974-04-201977-03-24 PROCESS FOR THE PRODUCTION OF NEW SALT OF CLAVULANIC ACID
AT205577AAT348124B (en)1974-04-201977-03-24 PROCESS FOR THE PRODUCTION OF NEW CLAVULAN ACID SALT
JP4026177AJPS533590A (en)1974-04-201977-04-05Purification of antibiotic
JP4026077AJPS533589A (en)1974-04-201977-04-05Purification of antibiotic
JP4025977AJPS533588A (en)1974-04-201977-04-05Production of antibiotic
JP4025877AJPS532495A (en)1974-04-201977-04-05Method of purifying antibiotics
JP4025777AJPS532494A (en)1974-04-201977-04-05Process for preparing antibiotics
FI780201AFI58332C (en)1974-04-201978-01-23 FOERFARANDE FOER FRAMSTAELLNING AV ESTRAR AV KLAVULANSYRA
FI780202AFI780202A (en)1974-04-201978-01-23 FOERFARANDE FOER FRAMSTAELLNING AV ETT HUVUDSAKLIGEN RENT SALT AV KLAVULANCY
DK287378ADK150489C (en)1974-04-201978-06-26 PROCEDURE FOR PREPARING A CLAVULANIC ACID SAL
DK287078ADK145543C (en)1974-04-201978-06-26 PROCEDURE FOR THE PREPARATION OF HYDRAULIZABLE ESTERS OF CLAVULANIC ACID
DK287278ADK150488C (en)1974-04-201978-06-26 PROCEDURE FOR INSULATING A CLAVULANIC ACID SAL
DK287178ADK287178A (en)1974-04-201978-06-26 PROCEDURE FOR PREPARING AN ANTIBIOTIC
US05/924,174US4556559A (en)1974-04-201978-07-13Antibiotics
SE7811200ASE435286B (en)1974-04-201978-10-27 CLAVULANIC ACID FOR USE AS A CHEMICAL INTERMEDIATE IN THE PRODUCTION OF CLAVULANIC ACID DERIVATIVES
SE7811201ASE446687B (en)1974-04-201978-10-27 PROCEDURE FOR PREPARING AN ANTIBACTERIAL, PHARMACEUTICAL PREPARATION WITH SYNERGISTIC EFFECT, INCLUDING CLAVULANIC ACID
SE7811203ASE443562B (en)1974-04-201978-10-27 PROCEDURE FOR PREPARING A PURE SALT OF CLAVULANIC ACID
SE7811202ASE435287B (en)1974-04-201978-10-27 ANALOGY PROCEDURE FOR THE PREPARATION OF CLAVULANIC ACID ESTERS
CA314,882ACA1076120A (en)1974-04-201978-10-30Clavulanic acid esters
CA314,881ACA1074325A (en)1974-04-201978-10-30Clavulanic acid and its salts
CA314,880ACA1055395A (en)1974-04-201978-10-30Antibiotics
NO791956ANO150838C (en)1974-04-201979-06-12 ANALOGY PROCEDURE FOR THE PREPARATION OF NEW CLAVULANIC ACID COMPOUNDS WITH ANTIBACTERIAL AND BETA-LACTAMASE INHIBITIVE PROPERTIES
NO801852ANO801852L (en)1974-04-201980-06-20 PHARMACEUTICAL CLAVULANIC ACID.
DK286980ADK157302C (en)1974-04-201980-07-02 ESTERS OF CLAVULANIC ACID USED AS INTERMEDIATES IN THE PRODUCTION OF CLAVULANIC ACID OR PHARMACEUTICAL TOLERABLE SALTS THEREOF
KE3076AKE3076A (en)1974-04-201980-08-29Novel b-lactam antibiotic from streptomyces clavuligerus
HK547/80AHK54780A (en)1974-04-201980-09-25Novel b-lactam antibiotic from streptomyces clavuligerus
CH947280ACH630631A5 (en)1974-04-201980-12-22 METHOD FOR PRODUCING CLAVULANIC ACID ESTERS AND THE USE THEREOF FOR PRODUCING CLAVULANIC ACID AND ITS SALTS.
US06/272,030US4526783A (en)1974-04-201981-06-09Antibiotic from S. clavuligerus
US06/305,337US4529720A (en)1974-04-201981-09-24Antibiotic from Streptomyces clavulicerus
SE8105829ASE453600B (en)1974-04-201981-10-02 PROCEDURE FOR PREPARING A SALT OF CLAVULANIC ACID
YU2743/81AYU42744B (en)1974-04-201981-11-23Process for obtaining clavulinic acid esthers
YU2744/81AYU42745B (en)1974-04-201981-11-23Process for obtaining clavulinic acid esthers
US06/327,253US4525352A (en)1974-04-201981-12-03Antibiotics
US06330456US4560552C1 (en)1974-04-201981-12-14Antibiotics
MY195/81AMY8100195A (en)1974-04-201981-12-30Novel b-lactam antibiotic from streptomyes clavuligerus
US06/352,951US4525353A (en)1974-04-201982-02-26Antibiotics
SE8306328ASE8306328D0 (en)1974-04-201983-11-16 ESTARS OF CLAVULANIC ACID
SE8605405ASE8605405D0 (en)1974-04-201986-12-16 PROCEDURE FOR PREPARING A SALT OF CLAVULANIC ACID

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
GB17410/74AGB1508977A (en)1974-04-201974-04-20Beta-lactam antibiotic from streptomyces clavuligerus

Publications (1)

Publication NumberPublication Date
GB1508977Atrue GB1508977A (en)1978-04-26

Family

ID=10094711

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GB17410/74AExpiredGB1508977A (en)1973-05-041974-04-20Beta-lactam antibiotic from streptomyces clavuligerus

Country Status (6)

CountryLink
AT (1)AT352270B (en)
BE (1)BE827926A (en)
CS (1)CS231157B2 (en)
GB (1)GB1508977A (en)
SU (1)SU648117A3 (en)
ZA (1)ZA752492B (en)

Cited By (40)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP0008525A2 (en)*1978-08-251980-03-05Beecham Group PlcPharmaceutical compositions and process for their preparation
JPS5559108A (en)*1978-10-271980-05-02Beecham Group LtdMammary gland composition
EP0026044B1 (en)*1979-08-241983-06-08Beecham Group PlcAmine salt of clavulanic acid, its preparation and use
GB2200355A (en)*1987-01-291988-08-03Beecham Group PlcPotassium clavulanate
EP0182522B1 (en)*1984-10-271991-06-19Beecham Group p.l.c.Preparation of clavulanic acid and its salts and esters
US5288861A (en)*1987-01-291994-02-22Beecham Group PlcPotassium clavulanate in rosette form
EP0594099A1 (en)*1992-10-211994-04-27Pharma Development Ltd.Process for the purification of crude clavulanic acid
EP0672669A1 (en)1992-06-111995-09-20Smithkline Beecham PlcProcess for the preparation of clavulanic acid
US5498788A (en)*1992-07-081996-03-12Lek, Tovarna FarmacevtskihInclusion complexes of clavulanic acid and of potassium salts thereof with hydrophobic β-cyclodextrin derivatives a process for the preparation thereof
WO1996018743A1 (en)*1994-12-101996-06-20Smithkline Beecham PlcProcess for the fermentative preparation of clavam derivatives whereby the levels of ammonia and urea in the fermentation medium are kept low
WO1996028452A1 (en)1995-03-101996-09-19Lek Pharmaceutical And Chemical Co. D.D.Process for the preparation of pharmaceutically acceptable salts of clavulanic acid
JPH08511010A (en)*1993-06-071996-11-19バイエル・アクチエンゲゼルシヤフト Cyclobutylazole
WO1997008175A1 (en)*1995-08-281997-03-06Lek Pharmaceutical & Chemical Co. DdIsolation of clavulanic acid from fermentation broth by ultrafiltration
EP0761218A1 (en)1994-04-231997-03-12Smithkline Beecham CorporationProcess for preparing polymer coated tablet comprising amoxycillin and clavunalate
WO1997019187A1 (en)*1995-11-231997-05-29Antibioticos, S.A.Process for the production of clavulanic acid and/or salts thereof
US5726170A (en)*1995-02-251998-03-10Spurcourt LimitedClavulanic acid salts
US5734048A (en)*1995-05-161998-03-31Chong Kun Dang Corp.Process for manufacturing clavulanic acid salt
US5750685A (en)*1987-01-291998-05-12Smithkline Beecham, P.L.C.Process for preparing potassium clavulanate in rossette form
US5859238A (en)*1992-03-261999-01-12Lek, Tovarna FarmacevtskihAlkylenediammonium diclavulanate derivatives, a process for the preparation thereof as well as the use thereof
US5985625A (en)*1994-03-021999-11-16Lek Pharmaceutical & Chemical Co. DdProcess for the isolation of clavulanic acid and of pharmaceutically acceptable salts thereof from the fermentation broth of Streptomyces sp. P 6621 FERM P 2804
WO2001012171A2 (en)*1999-08-162001-02-22Revaax Pharmaceuticals, LlcPharmaceutical compositions comprising clavulanic acid or derivative thereof for the treatment of behavioral diseases
US6194001B1 (en)1996-08-062001-02-27Quadrant Holdings Cambridge Ltd.Tablet dosage form of clavulanic acid and amoxycillin comprising a trehalose excipient
EP0741732B1 (en)*1994-02-022001-06-20Smithkline Beecham PlcProcess for the preparation of a salt of clavulanic acid
US6414142B1 (en)*1996-06-132002-07-02Smithkline Beecham CorporationProcess for preparing potassium clavulanate
US6426342B2 (en)1999-08-162002-07-30Revaax Pharmaceuticals, LlcUse of β-lactamase inhibitors as neuroprotectants
US6489319B2 (en)1999-08-162002-12-03Revaax Pharmaceuticals, LlcNeurotherapeutic use of carboxypeptidase inhibitors
EP0941229B1 (en)*1996-11-272003-09-03BIOCHEMIE Gesellschaft m.b.H.Purification of fermented clavulanic acid
US6660299B2 (en)1999-04-132003-12-09Beecham Pharmaceuticals LimitedModified release pharmaceutical formulation comprising amoxycillin
US6746692B2 (en)1999-04-132004-06-08Beecham Pharmaceuticals (Pte) LimitedModified release pharmaceutical formulation comprising amoxycillin
US6756057B2 (en)2000-10-122004-06-29Beecham Pharmaceuticals (Pte) LimitedAmoxicillin and potassium clavulanate dosage form
US6783773B1 (en)1999-04-132004-08-31Beecham Pharmaceuticals (Pte) LimitedComposition comprising amoxicillin and potassium clavulanate
US7011849B2 (en)2000-10-122006-03-14Beecham Pharmaceuticals (Pte) LimitedSecond release phase formulation
USH2158H1 (en)1992-03-102006-06-06Sandoz AgProcess for the production of clavulanic acid salts
US7767823B2 (en)2000-05-132010-08-03Smithkline Beecham LimitedProcess for the purification of a salt of clavulanic acid
ES2357595A1 (en)*2009-10-022011-04-28Instituto Mediterraneo Para El Avance De La Biotecnologia Y La Investigacion Sanitaria (Fundacion Im CLAVULANIC ACID COMPOSITION AND USE FOR DIAGNOSIS IN ALLERGOLOGY.
WO2011078820A1 (en)2009-12-252011-06-30Mahmut BilgicPharmaceutical formulations comprising a third generation cephalosporin and clavulanic acid
WO2011093829A1 (en)2010-01-292011-08-04Mahmut BilgicEffervescent formulations comprising cefixime and clavulanic acid as active agents
WO2011093827A1 (en)2010-01-292011-08-04Mahmut BilgicWater dispersible cefdinir and clavulanic acid formulations for treatment of bacterial infections
WO2011093826A2 (en)2010-01-292011-08-04Mahmut BilgicEffervescent formulations comprising cefaclor and clavulanic acid as active agents
CN115433701A (en)*2022-11-082022-12-06南京农业大学 A strain of Proteus and its agent and its application in degrading cephalosporin antibiotics

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4098897A (en)1975-04-141978-07-04Beecham Group LimitedAnti bacterial agents
IE44295B1 (en)*1975-10-131981-10-07Beecham Group LtdClavulanic acid derivatives
GB1582884A (en)*1977-05-191981-01-14Beecham Group LtdClavulanic acid derivatives their preparation and use
US4454069A (en)*1979-08-241984-06-12Beecham Group LimitedClavulanic acid salts and their preparation from the tertiary butyl amine salt
EP2589663A1 (en)2011-11-042013-05-08LEK Pharmaceuticals d.d.Process for production of clavulanic acid

Cited By (70)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP0008525A3 (en)*1978-08-251980-05-28Beecham Group PlcPharmaceutical compositions and process for their preparation
EP0008525A2 (en)*1978-08-251980-03-05Beecham Group PlcPharmaceutical compositions and process for their preparation
JPH0223530B2 (en)*1978-10-271990-05-24Beecham Group Plc
JPS5559108A (en)*1978-10-271980-05-02Beecham Group LtdMammary gland composition
EP0010904A2 (en)*1978-10-271980-05-14Beecham Group PlcIntramammary compositions and process for their preparation
EP0010904A3 (en)*1978-10-271980-07-23Beecham Group LimitedIntramammary compositions and process for their preparation
EP0026044B1 (en)*1979-08-241983-06-08Beecham Group PlcAmine salt of clavulanic acid, its preparation and use
EP0182522B1 (en)*1984-10-271991-06-19Beecham Group p.l.c.Preparation of clavulanic acid and its salts and esters
GB2200355A (en)*1987-01-291988-08-03Beecham Group PlcPotassium clavulanate
GB2200355B (en)*1987-01-291990-08-01Beecham Group PlcPotassium clavulanate
EP0277008A1 (en)*1987-01-291988-08-03Beecham Group PlcProcess for crystallization of potassium clavulanate
US5288861A (en)*1987-01-291994-02-22Beecham Group PlcPotassium clavulanate in rosette form
US5750685A (en)*1987-01-291998-05-12Smithkline Beecham, P.L.C.Process for preparing potassium clavulanate in rossette form
USH2158H1 (en)1992-03-102006-06-06Sandoz AgProcess for the production of clavulanic acid salts
US5859238A (en)*1992-03-261999-01-12Lek, Tovarna FarmacevtskihAlkylenediammonium diclavulanate derivatives, a process for the preparation thereof as well as the use thereof
EP0672670A1 (en)1992-06-111995-09-20Smithkline Beecham PlcProcess for the preparation of clavulanic acid
EP0699682A1 (en)1992-06-111996-03-06Smithkline Beecham P.L.C.Process for the preparation and/or purification of clavulanic acid
DE4345311C1 (en)*1992-06-111996-02-01Smithkline Beecham Plc Process for the production and / or purification of clavulanic acid
EP0801069A1 (en)*1992-06-111997-10-15Smithkline Beecham PlcProcess for the preparation of clavulanic acid
EP0672669A1 (en)1992-06-111995-09-20Smithkline Beecham PlcProcess for the preparation of clavulanic acid
EP0806426A1 (en)*1992-06-111997-11-12Smithkline Beecham PlcProcess for the preparation of clavulanic acid
EP0672669B1 (en)*1992-06-111997-09-10Smithkline Beecham PlcProcess for the preparation of potassium clavulanate
US5498788A (en)*1992-07-081996-03-12Lek, Tovarna FarmacevtskihInclusion complexes of clavulanic acid and of potassium salts thereof with hydrophobic β-cyclodextrin derivatives a process for the preparation thereof
US5608052A (en)*1992-07-081997-03-04Lek, Tovarna Farmacevtskih In KemicnihInclusioin complexes of clavulanic acid and of alkali salts thereof with hydrophilic and hydrophobic beta-cyclodextrin derivatives, a process for the preparation thereof and the use thereof
US5614199A (en)*1992-07-081997-03-25Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D., LjubljanaInclusion complexes of clavulanic acid and of alkali salts thereof with hydrophilic and hydrophobic β-cyclodextrin derivatives, a process for the preparation thereof and the use thereof
EP0594099A1 (en)*1992-10-211994-04-27Pharma Development Ltd.Process for the purification of crude clavulanic acid
JPH08511010A (en)*1993-06-071996-11-19バイエル・アクチエンゲゼルシヤフト Cyclobutylazole
EP0741732B1 (en)*1994-02-022001-06-20Smithkline Beecham PlcProcess for the preparation of a salt of clavulanic acid
US5985625A (en)*1994-03-021999-11-16Lek Pharmaceutical & Chemical Co. DdProcess for the isolation of clavulanic acid and of pharmaceutically acceptable salts thereof from the fermentation broth of Streptomyces sp. P 6621 FERM P 2804
EP0761218A1 (en)1994-04-231997-03-12Smithkline Beecham CorporationProcess for preparing polymer coated tablet comprising amoxycillin and clavunalate
US6235506B1 (en)1994-12-102001-05-22Smithkline Beecham, P.L.C.Process for the fermentative preparation of clavam derivatives whereby the levels of ammonia and urea in the fermentation medium are kept low
US5985624A (en)*1994-12-101999-11-16Smithkline Beecham P.L.C.Process for the fermentative preparation of clavam derivatives whereby the levels of ammonia and urea in the fermentation medium are kept low
CN1119423C (en)*1994-12-102003-08-27史密丝克莱恩比彻姆有限公司Process for fermentative prepn. of clavam derivatives whereby the levels of ammonia and urea in the fermentation medium are kept low
WO1996018743A1 (en)*1994-12-101996-06-20Smithkline Beecham PlcProcess for the fermentative preparation of clavam derivatives whereby the levels of ammonia and urea in the fermentation medium are kept low
US5726170A (en)*1995-02-251998-03-10Spurcourt LimitedClavulanic acid salts
WO1996028452A1 (en)1995-03-101996-09-19Lek Pharmaceutical And Chemical Co. D.D.Process for the preparation of pharmaceutically acceptable salts of clavulanic acid
US5994534A (en)*1995-03-101999-11-30Lek Pharmaceutical And Chemical Co. D.DProcess for the preparation of pharmaceutically acceptable salts of clavulanic acid
US5734048A (en)*1995-05-161998-03-31Chong Kun Dang Corp.Process for manufacturing clavulanic acid salt
CN1101396C (en)*1995-08-282003-02-12莱柯·药品及化学制品公司Isolation of clavulanic acid from fermentation broth by ultrafiltration
US6127358A (en)*1995-08-282000-10-03Urquhart-Dykes & LordIsolation of clavulanic acid from fermentation broth by ultrafiltration
WO1997008175A1 (en)*1995-08-281997-03-06Lek Pharmaceutical & Chemical Co. DdIsolation of clavulanic acid from fermentation broth by ultrafiltration
US6274575B1 (en)1995-08-282001-08-14Lek Pharmaceutical And Chemical Co. D. D.Isolation of clavulanic acid from fermentation broth by ultrafiltration
CN1113965C (en)*1995-11-232003-07-09抗生素股份公司Process for production of clavulanic acid and/or salts thereof
US6100052A (en)*1995-11-232000-08-08Antibioticos, S.A.Process for the production of clavulanic acid and/or salts thereof by fermentation controlling soluble phosphate concentration
WO1997019187A1 (en)*1995-11-231997-05-29Antibioticos, S.A.Process for the production of clavulanic acid and/or salts thereof
ES2101658A1 (en)*1995-11-231997-07-01Antibioticos SaProcess for the production of clavulanic acid and/or salts thereof
US6414142B1 (en)*1996-06-132002-07-02Smithkline Beecham CorporationProcess for preparing potassium clavulanate
US6194001B1 (en)1996-08-062001-02-27Quadrant Holdings Cambridge Ltd.Tablet dosage form of clavulanic acid and amoxycillin comprising a trehalose excipient
EP0941229B1 (en)*1996-11-272003-09-03BIOCHEMIE Gesellschaft m.b.H.Purification of fermented clavulanic acid
US6878386B1 (en)1999-04-132005-04-12Beecham Pharmaceuticals (Pte) LimitedMethod of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6660299B2 (en)1999-04-132003-12-09Beecham Pharmaceuticals LimitedModified release pharmaceutical formulation comprising amoxycillin
US6783773B1 (en)1999-04-132004-08-31Beecham Pharmaceuticals (Pte) LimitedComposition comprising amoxicillin and potassium clavulanate
US7250176B1 (en)1999-04-132007-07-31Beecham Pharmaceuticals (Pte) LimitedMethod of treating a bacterial infection
US6746692B2 (en)1999-04-132004-06-08Beecham Pharmaceuticals (Pte) LimitedModified release pharmaceutical formulation comprising amoxycillin
WO2001012171A2 (en)*1999-08-162001-02-22Revaax Pharmaceuticals, LlcPharmaceutical compositions comprising clavulanic acid or derivative thereof for the treatment of behavioral diseases
WO2001012171A3 (en)*1999-08-162002-01-17Revaax Pharmaceuticals LlcPharmaceutical compositions comprising clavulanic acid or derivative thereof for the treatment of behavioral diseases
US7842683B2 (en)*1999-08-162010-11-30Revaax Pharmaceuticals, LlcNeurotherapeutic compositions and method
US6610681B1 (en)1999-08-162003-08-26Revaax Pharmaceuticals, LlcNeurotherapeutic clavulanate composition and method
US6489319B2 (en)1999-08-162002-12-03Revaax Pharmaceuticals, LlcNeurotherapeutic use of carboxypeptidase inhibitors
US6627625B1 (en)1999-08-162003-09-30Revaax Pharmaceuticals, LlcTreatment of behavioral disorders with β-lactam compounds
US6426342B2 (en)1999-08-162002-07-30Revaax Pharmaceuticals, LlcUse of β-lactamase inhibitors as neuroprotectants
US7767823B2 (en)2000-05-132010-08-03Smithkline Beecham LimitedProcess for the purification of a salt of clavulanic acid
US7011849B2 (en)2000-10-122006-03-14Beecham Pharmaceuticals (Pte) LimitedSecond release phase formulation
US6756057B2 (en)2000-10-122004-06-29Beecham Pharmaceuticals (Pte) LimitedAmoxicillin and potassium clavulanate dosage form
ES2357595A1 (en)*2009-10-022011-04-28Instituto Mediterraneo Para El Avance De La Biotecnologia Y La Investigacion Sanitaria (Fundacion Im CLAVULANIC ACID COMPOSITION AND USE FOR DIAGNOSIS IN ALLERGOLOGY.
WO2011078820A1 (en)2009-12-252011-06-30Mahmut BilgicPharmaceutical formulations comprising a third generation cephalosporin and clavulanic acid
WO2011093829A1 (en)2010-01-292011-08-04Mahmut BilgicEffervescent formulations comprising cefixime and clavulanic acid as active agents
WO2011093827A1 (en)2010-01-292011-08-04Mahmut BilgicWater dispersible cefdinir and clavulanic acid formulations for treatment of bacterial infections
WO2011093826A2 (en)2010-01-292011-08-04Mahmut BilgicEffervescent formulations comprising cefaclor and clavulanic acid as active agents
CN115433701A (en)*2022-11-082022-12-06南京农业大学 A strain of Proteus and its agent and its application in degrading cephalosporin antibiotics

Also Published As

Publication numberPublication date
ZA752492B (en)1976-06-30
BE827926A (en)1975-10-14
SU648117A3 (en)1979-02-15
ATA298575A (en)1979-02-15
CS231157B2 (en)1984-10-15
CS272175A2 (en)1984-02-13
AT352270B (en)1979-09-10

Similar Documents

PublicationPublication DateTitle
GB1508977A (en)Beta-lactam antibiotic from streptomyces clavuligerus
US4650795A (en)Amine salts of clavulanic acid as antibacterial agents
IE41109B1 (en)Novel -lactam antibiotic from streptomyces clavuligerus
KR950703346A (en) Crystalline Penicillin Derivatives, Their Preparation and Uses (Crystalline Penicillin Derivative, and Its Production and Use)
GB1221855A (en)Penicillin and cephalosporin derivatives
US4438101A (en)Antibiotics
GB1505885A (en)Substituted cephalosporins
GB1515241A (en)Beta-lactam antibiotics
IE39216L (en)Pharmaceutical tablets
US4428958A (en)Therapeutic compounds containing β-lactams
GB1508978A (en)Esters of clavulanic acid
US5049384A (en)Antibacterial composition for medical use and a process for the preparation thereof
GB1311498A (en)Penicillin and cephalosporin derivatives
ES461691A1 (en)Beta-lactam antibiotics
GB1377661A (en)Oxofuryl ester derivatives of penicillin and cephalosporin
US4524073A (en)β-Lactam compounds
EP0055062B1 (en)Compounds containing beta-lactams
US4242262A (en)9-Nitromethyldeoxyclavulanic acid derivatives preparation and compositions
GB1504426A (en)Clavulanic acid derivatives
US4303665A (en)Methylaminodeoxy-clavulanic acid derivatives, their production and use
IT1036078B (en)Beta-Lactam antibiotic combination preparations - contg a 7-tetrazolylacetamido-cephem cpd and penicillin
CA1068603A (en)Preparations comprising phosphonomycin and another antibiotic
US4036969A (en)2,12-Dioxo-7-hydroxymethyl-9-phenyl-1-aza-5,8,11-trioxotetracyclo[9.2.0.06,13 0.6.9 ]tridecane
ES8301236A1 (en)Chemical compound
EP0007717B1 (en)Clavulanic acid derivatives, a process for their preparation, their use, and pharmaceutical compositions containing them

Legal Events

DateCodeTitleDescription
PSPatent sealed
704ADeclaration that licence is not available as of right for an excepted use (par. 4a/1977)
PE20Patent expired after termination of 20 years

Effective date:19950410


[8]ページ先頭

©2009-2025 Movatter.jp